Document is current
Any future updates will be listed below
-
Authors
Hajam, Irshad Ahmed https://orcid.org/0000-0003-4010-1845
Tsai, Chih-Ming
Gonzalez, Cesia
Caldera, Juan Raphael https://orcid.org/0000-0003-0563-8815
Lázaro Díez, María https://orcid.org/0000-0002-6098-8052
Du, Xin https://orcid.org/0000-0002-6907-3609
Aralar, April https://orcid.org/0000-0002-2944-3417
Lin, Brian https://orcid.org/0009-0005-9482-416X
Duong, William
Liu, George Y. https://orcid.org/0000-0003-0759-0587
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI127406, R01AI179098, R01AI181321, R01AI144694)
- License Information
-
More Information
Article History
Received: 28 November 2023
Accepted: 18 November 2024
First Online: 16 December 2024
Competing interests
: I.A.H. and G.Y.L. have filed a patent application for the use of vaccine adjuvants that mediate efficient IL-17 type-immunity. All other authors declare no competing interests.
